Evidence map›Paper›PMID 42732002›Full record

ArticleEMBO reports2026

Orphan GPR84 facilitates uropod de-adhesion at multiple steps during leukocyte extravasation.

Clare Latta, Terrence M Trinca, Francesca Robertson, Rachel Lau, Anna Barkaway, Loïc Rolas, Matthew Golding, Paul R C Imbert, Haitao Wang, Almke Bader and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Clare Latta *Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0009-0007-4686-9253
Terrence M Trinca *School of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK.ORCID http://orcid.org/0009-0002-0333-683X
Francesca RobertsonSchool of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK.
Rachel LauExperimental Medicine and Rheumatology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Anna BarkawayCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Loïc RolasCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-7617-0768
Matthew GoldingCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Paul R C ImbertCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-1870-1249
Haitao WangCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Almke BaderInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Munich, Germany.
Liam S HillSchool of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK.
Lorna HodgsonSchool of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK.
Yue YangCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
Aleksandar IveticSchool of Cardiovascular and Metabolic Medicine and Sciences, James Black Centre, BHF Centre of Research Excellence, King's College London, London, UK.ORCID http://orcid.org/0000-0001-9844-6518
Barbara WalzogInstitute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Munich, Germany.
Myles LewisExperimental Medicine and Rheumatology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-9365-5345
Mathieu-Benoit VoisinCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0003-3001-0894
Paul Martin *School of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK. paul.martin@bristol.ac.uk.ORCID http://orcid.org/0000-0002-2665-5086
Sussan Nourshargh *Centre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. s.nourshargh@qmul.ac.uk.ORCID http://orcid.org/0000-0001-5677-1806
Helen Weavers *School of Biochemistry, Biomedical Sciences Building, University of Bristol, Bristol, UK. helen.weavers@bristol.ac.uk.ORCID http://orcid.org/0000-0002-5383-6085

Funding

UKRI | Medical Research Council (MRC) MR/V011294/1Wellcome Trust (WT) 208762/Z/17/ZWellcome Trust (WT) 217169/Z/19/ZWellcome Trust (WT) 221699/Z/20/ZWellcome Trust (WT) 317089/Z/24/Z
6 · The paper itself

Abstract

Leukocyte migration through venular walls is an essential component of effective immunity. While the key molecular players driving the initial steps of this response are known, the terminating signals remain unclear. Here, we identify a conserved role for GPR84 family GPCRs in the successful completion of the final stages of leukocyte extravasation through acutely inflamed vessels. The integration of high-resolution intravital imaging with cell-specific genetics reveals that the deficiency of GPR84 orthologs in mice and Drosophila results in flawed detachment of transmigrating immune cells from vessel walls. Mechanistically, transcriptomics reveals that GPR84-deficient neutrophils exhibit defective actin cytoskeletal regulation and cellular adhesion/de-adhesion. Consistent with this, our fly-murine pipeline shows that GPR84 supports localized and dynamic Rho activation to enable detachment of the immune cell uropod from vessel exit sites. Moreover, pharmacological blockade of GPR84 signaling dampens immune cell migration in multiple murine acute inflammatory settings. Collectively, our findings present GPR84 as a novel physiological regulator of immune cell extravasation that is amenable to therapeutic targeting for modulating leukocyte infiltration into inflamed tissues.

Identifiers

PMID42732002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.